Page last updated: 2024-11-05

ticlopidine and Osteogenesis Imperfecta

ticlopidine has been researched along with Osteogenesis Imperfecta in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Osteogenesis Imperfecta: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajsadeghi, S1
Jafarian Kerman, SR1
Pouraliakbar, H1
Mohammadi, R1

Other Studies

1 other study available for ticlopidine and Osteogenesis Imperfecta

ArticleYear
A huge coronary artery aneurysm in osteogenesis imperfecta: a case report.
    Acta medica Iranica, 2012, Volume: 50, Issue:11

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Aneurysm; Drug Therap

2012